News & Updates

The Stanford neuromodulation therapy (SNT), a high-dose intermittent theta-burst stimulation (iTBS) protocol with functional-connectivity-guided targeting, demonstrates better efficacy than sham stimulation for treatment-resistant depression, according to the results of a double-blind, randomized controlled trial.

High selenium intake seems to exert a significant protective effect against postpartum depression, reports a recent meta-analysis. Selenium may be considered as a potential adjuvant therapy in patients with depression.

The prevalence of depression is relatively high among children, adolescents, and adults with hidradenitis suppurativa (HS), a chronic inflammatory skin disorder, according to a study, which also notes the importance of periodic screening for depression.

Moderate to severe symptoms of anxiety and depression have been reported in about one-fourth of children with juvenile idiopathic arthritis (JIA), according to a study. Such symptoms are associated with pain and stress, but not with other disease manifestations.

The orally bioavailable, investigational neuroactive steroid zuranolone appears to be beneficial in the treatment of insomnia, producing improvements in sleep measures, including sleep efficiency, duration of awakenings, and total sleep time in adults, according to the results of a phase I study.